EP3170495 - GEMCABENE FOR TREATING PANCREATITIS [Right-click to bookmark this link] | |||
Former [2017/21] | GEMCABEN FOR TREATING PANCREATITIS | ||
[2022/12] | Status | No opposition filed within time limit Status updated on 01.03.2024 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 24.03.2023 | ||
Former | Grant of patent is intended Status updated on 24.11.2022 | ||
Former | Examination is in progress Status updated on 13.09.2022 | ||
Former | Grant of patent is intended Status updated on 17.05.2022 | ||
Former | Examination is in progress Status updated on 25.09.2020 | ||
Former | Request for examination was made Status updated on 24.11.2017 | ||
Former | The application has been published Status updated on 21.04.2017 | Most recent event Tooltip | 30.08.2024 | Lapse of the patent in a contracting state New state(s): LU, MC | published on 02.10.2024 [2024/40] | Applicant(s) | For all designated states Gemphire Therapeutics Inc. 17199 N. Laurel Park Drive, Suite 401 Livonia, MI 48152 / US | [2018/12] |
Former [2017/21] | For all designated states Gemphire Therapeutics Inc. 43334 Seven Mile Road, Suite 1000 Northville, MI 48167 / US | Inventor(s) | 01 /
BISGAIER, Charles, L. 3605 Tanglewood Dr. Ann Arbor, MI Michigan 48105 / US | [2017/21] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2017/21] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 16192597.9 | 22.12.2011 | [2017/21] | Priority number, date | US201061427236P | 27.12.2010 Original published format: US 201061427236 P | [2017/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3170495 | Date: | 24.05.2017 | Language: | EN | [2017/21] | Type: | B1 Patent specification | No.: | EP3170495 | Date: | 26.04.2023 | Language: | EN | [2023/17] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 05.04.2017 | Classification | IPC: | A61K31/19, A61P1/18 | [2017/21] | CPC: |
A61K31/19 (EP,CN,US);
A61P1/18 (EP);
A61P29/00 (EP);
A61P3/06 (EP);
A61P43/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/52] |
Former [2017/21] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 20.11.2017 | ME | 20.11.2017 | Title | German: | GEMCABEN ZUR BEHANDLUNG VON PANKREATITIS | [2017/21] | English: | GEMCABENE FOR TREATING PANCREATITIS | [2022/12] | French: | GEMCABÈNE POUR LE TRAITEMENT DE LA PANCRÉATITE | [2017/21] |
Former [2017/21] | GEMCABEN FOR TREATING PANCREATITIS | Examination procedure | 06.10.2016 | Date on which the examining division has become responsible | 20.11.2017 | Examination requested [2017/52] | 09.01.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 08.03.2018 | Amendment by applicant (claims and/or description) | 25.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 21.01.2021 | Reply to a communication from the examining division | 18.05.2022 | Communication of intention to grant the patent | 09.09.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 25.11.2022 | Communication of intention to grant the patent | 14.03.2023 | Fee for grant paid | 14.03.2023 | Fee for publishing/printing paid | 14.03.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11810759.8 / EP2658536 | Opposition(s) | 29.01.2024 | No opposition filed within time limit [2024/14] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 08.03.2018 | Request for further processing filed | 08.03.2018 | Full payment received (date of receipt of payment) Request granted | 21.03.2018 | Decision despatched | Fees paid | Renewal fee | 02.11.2016 | Renewal fee patent year 03 | 02.11.2016 | Renewal fee patent year 04 | 02.11.2016 | Renewal fee patent year 05 | 02.11.2016 | Renewal fee patent year 06 | 12.12.2017 | Renewal fee patent year 07 | 12.12.2018 | Renewal fee patent year 08 | 13.12.2019 | Renewal fee patent year 09 | 09.12.2020 | Renewal fee patent year 10 | 16.12.2021 | Renewal fee patent year 11 | 09.12.2022 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 26.04.2023 | CZ | 26.04.2023 | DK | 26.04.2023 | EE | 26.04.2023 | ES | 26.04.2023 | FI | 26.04.2023 | HR | 26.04.2023 | IT | 26.04.2023 | LT | 26.04.2023 | LV | 26.04.2023 | MC | 26.04.2023 | NL | 26.04.2023 | PL | 26.04.2023 | RO | 26.04.2023 | RS | 26.04.2023 | SE | 26.04.2023 | SI | 26.04.2023 | SK | 26.04.2023 | SM | 26.04.2023 | NO | 26.07.2023 | GR | 27.07.2023 | IS | 26.08.2023 | PT | 28.08.2023 | LU | 22.12.2023 | [2024/40] |
Former [2024/26] | AT | 26.04.2023 | |
CZ | 26.04.2023 | ||
DK | 26.04.2023 | ||
EE | 26.04.2023 | ||
ES | 26.04.2023 | ||
FI | 26.04.2023 | ||
HR | 26.04.2023 | ||
IT | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RO | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
SI | 26.04.2023 | ||
SK | 26.04.2023 | ||
SM | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2024/24] | AT | 26.04.2023 | |
CZ | 26.04.2023 | ||
DK | 26.04.2023 | ||
EE | 26.04.2023 | ||
ES | 26.04.2023 | ||
FI | 26.04.2023 | ||
HR | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RO | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
SI | 26.04.2023 | ||
SK | 26.04.2023 | ||
SM | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2024/10] | AT | 26.04.2023 | |
CZ | 26.04.2023 | ||
DK | 26.04.2023 | ||
EE | 26.04.2023 | ||
ES | 26.04.2023 | ||
FI | 26.04.2023 | ||
HR | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RO | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
SK | 26.04.2023 | ||
SM | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2024/08] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
FI | 26.04.2023 | ||
HR | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
SK | 26.04.2023 | ||
SM | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2024/03] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
FI | 26.04.2023 | ||
HR | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2024/01] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
HR | 26.04.2023 | ||
LT | 26.04.2023 | ||
LV | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2023/51] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
HR | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
RS | 26.04.2023 | ||
SE | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2023/50] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
NL | 26.04.2023 | ||
PL | 26.04.2023 | ||
SE | 26.04.2023 | ||
NO | 26.07.2023 | ||
GR | 27.07.2023 | ||
IS | 26.08.2023 | ||
PT | 28.08.2023 | ||
Former [2023/48] | AT | 26.04.2023 | |
ES | 26.04.2023 | ||
NL | 26.04.2023 | ||
SE | 26.04.2023 | ||
NO | 26.07.2023 | ||
PT | 28.08.2023 | ||
Former [2023/46] | ES | 26.04.2023 | |
NL | 26.04.2023 | ||
PT | 28.08.2023 | ||
Former [2023/43] | NL | 26.04.2023 | Documents cited: | Search | [A]EP0369035 (SHOWA DENKO KK [JP], et al) [A] 1-15* the whole document *; | [AD]US2003018013 (DASSEUX JEAN-LOUIS HENRI [US], et al) [AD] 1-15 * the whole document *; | [YD] - BAYS H.E. ET AL., "Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol", AM J CARDIOL, (2003), vol. 92, pages 538 - 543, XP009158006 [YD] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/S0002-9149(03)00721-5 | [YD] - AMERICAN HEART ASSOCIATION, "Third report of the national cholesterol education program expert panel and detection, evaluation and treatment of high blood cholesterol in adults", CIRCULATION, (20021217), vol. 106, ISSN 1524-4539, XP002672662 [YD] 1-15 * Document consists of pages 3247, 3331 - 3333 * | by applicant | US5648387 | US6410802 | US2002103252 | US6459003 | US6645170 | US6713507 | US6790953 | US6861555 | US7192940 | US7345190 | - BAYS, AM. J. CARDIOL., (2003), vol. 92, pages 538 - 543 | - BAYS H.E ET AL., AM J CARDIOL, (2003), vol. 92, pages 538 - 543 |